Neurava Secures $2.26M Seed Funding to Advance Wearable Seizure Detection Technology

INDIANAPOLISNeurava, a medical technology startup specializing in wearable devices, today announced the successful closure of its $2.26 million seed funding round. The round was led by Life Science Angels, with a follow-on investment from UCB and participation from Purdue Innovates, Elevate Ventures, Rivermount Ventures, and First Leaf Capital. The company plans to utilize the funding for pivotal usability studies, manufacturing partnerships, and FDA clearance submissions.

Founded by CEO Jay Shah and CTO Vivek Ganesh, Neurava is developing innovative wearable devices that aim to detect and alert for seizures, cardiorespiratory issues, and risk of Sudden Unexpected Death in Epilepsy (SUDEP). Neurava’s technology holds the potential to transform the lives of patients with epilepsy worldwide.

Advances in Wearable Medical Devices

Neurava is part of a growing wave of companies revolutionizing healthcare with wearable technology. Here are other notable startups in the sector:

  • Empatica: Develops wearables that track physiological stress markers providing insights into mental health and well-being.
  • BioIntelliSense: Creates medical-grade wearables for continuous remote patient monitoring.
  • NeuroSigma: Focuses on trigeminal nerve stimulation wearables as a potential non-drug therapy for epilepsy.
Deal Highlights
HeadquartersIndianapolis, IN
Funding RoundSeed
Amount Raised$2.26 million
Lead InvestorLife Science Angels
Other InvestorsUCB, Purdue Innovates, Elevate Ventures, Rivermount Ventures, First Leaf Capital

Neurava Medtech

Neurava is a MedTech company developing wearable devices for seizure detection and health monitoring. Founded by Jay Shah and Vivek Ganesh, the company is committed to improving the lives of individuals with epilepsy.

Related Posts